文献速递系统性红斑狼疮其他结缔组织病

CDKN1B rs34330 通过调控多靶基因影响系统性红斑狼疮易感性

Lupus Susceptibility Region Containing CDKN1B rs34330 Mechanistically Influences Expression and Function of Multiple Target Genes, Also Linked to Proliferation and Apoptosis.
PubMed 文献 · Arthritis Rheumatol · 2021-10-29

该研究在汉族人群中验证了 CDKN1B rs34330 与系统性红斑狼疮(SLE)的遗传关联,并通过 meta 分析(n=28,872)得出 P=5.29×10-22、OR=0.84(95%CI 0.81-0.87)。机制上,rs34330 位于活跃染色质,通过等位基因特异性启动子/增强子活性及组蛋白修饰、RNA Pol II、IRF-1 结合调控 APOLD1、DDX47、CDKN1B 等靶基因,并影响细胞增殖与凋亡。

要点

  • rs34330 与 SLE 关联获验证:meta 分析 P=5.29×10-22,OR=0.84(95%CI 0.81-0.87)。
  • rs34330 位于活跃染色质,具等位基因特异性启动子与增强子活性。
  • 风险等位基因 C 影响组蛋白修饰、RNA Pol II 及 IRF-1 结合,调控靶基因表达。

核心结论

  • rs34330 风险等位基因 C 通过影响组蛋白修饰、RNA Pol II 和 IRF-1 结合调控多个靶基因表达,可能构成其与 SLE 关联的机制。

研究设计与样本

  • 在 SLE 患者中行等位基因关联分析,并对 11 个独立队列(n=28,872)的 GWAS 数据进行 meta 分析。
  • 采用生物信息学分析及 SLE 相关细胞系实验验证 rs34330 的功能后果。

主要发现

  • meta 分析复现 rs34330 与 SLE 的遗传关联:P=5.29×10-22,OR=0.84(95%CI 0.81-0.87)。
  • 荧光素酶和 ChIP-qPCR 显示 rs34330 具等位基因特异性启动子与增强子活性,及 3 种组蛋白修饰(H3K27ac、H3K4me3、H3K4me1)、RNA Pol II、CTCF 和 IRF-1 的等位基因特异性结合。
  • 染色体构象捕获揭示 rs34330 与邻近基因 APOLD1 和 DDX47 启动子存在长程染色质互作。
  • CRISPR 基因组编辑直接验证 rs34330 对 CDKN1B 及其他靶基因表达的影响,CRISPR/dCas9 表观激活/沉默确认结果。
  • 基因编辑细胞系显示更高的增殖与凋亡水平。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In a recent genome-wide association study, a significant genetic association between rs34330 of CDKN1B and risk of systemic lupus erythematosus (SLE) in Han Chinese was identified. This study was undertaken to validate the reported association and elucidate the biochemical mechanisms underlying the effect of the variant. METHODS: We performed an allelic association analysis in patients with SLE, followed by a meta-analysis assessing genome-wide association data across 11 independent cohorts (n = 28,872). In silico bioinformatics analysis and experimental validation in SLE-relevant cell lines were applied to determine the functional consequences of rs34330. RESULTS: We replicated a genetic association between SLE and rs34330 (meta-analysis P = 5.29 × 10-22 , odds ratio 0.84 [95% confidence interval 0.81-0.87]). Follow-up bioinformatics and expression quantitative trait locus analysis suggested that rs34330 is located in active chromatin and potentially regulates several target genes. Using luciferase and chromatin immunoprecipitation-real-time quantitative polymerase chain reaction, we demonstrated substantial allele-specific promoter and enhancer activity, and allele-specific binding of 3 histone marks (H3K27ac, H3K4me3, and H3K4me1), RNA polymerase II (Pol II), CCCTC-binding factor, and a critical immune transcription factor (interferon regulatory factor 1 [IRF-1]). Chromosome conformation capture revealed long-range chromatin interactions between rs34330 and the promoters of neighboring genes APOLD1 and DDX47, and effects on CDKN1B and the other target genes were directly validated by clustered regularly interspaced short palindromic repeat (CRISPR)-based genome editing. Finally, CRISPR/dead CRISPR-associated protein 9-based epigenetic activation/silencing confirmed these results. Gene-edited cell lines also showed higher levels of proliferation and apoptosis. CONCLUSION: Collectively, these findings suggest a mechanism whereby the rs34330 risk allele (C) influences the presence of histone marks, RNA Pol II, and IRF-1 transcription factor to regulate expression of several target genes linked to proliferation and apoptosis. This process could potentially underlie the association of rs34330 with SLE.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Singh B, Maiti GP, Zhou X, et al. Lupus Susceptibility Region Containing CDKN1B rs34330 Mechanistically Influences Expression and Function of Multiple Target Genes, Also Linked to Proliferation and Apoptosis. Arthritis Rheumatol. 2021. PMID: 33982894. doi:10.1002/art.41799

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。